ANGPTL3 and polycystic ovary syndrome: Our study indicates that patients at risk of developing PCOS can be metabolically identified through a combination of ANGPTL3, 4, 8, omentin-1, leptin, IL-6, TNF-α, CRP, LDL, and BMI.